Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kosuke Imamura

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Cancer Research|July 22, 2021
TGFβ Signaling Activated by Cancer-Associated Fibroblasts Determines the Histological Signature of Lung AdenocarcinomaRyo Sato, Kosuke Imamura, Takashi Semba, et al.
Internal Medicine (Tokyo, Japan)|December 25, 2024
A Case of Rapid Emergence of Small-cell Carcinoma due to Malignant Transformation or de novo Formation in the Anterior Mediastinum Following Thymoma Resection: The Importance of a Re-biopsyYasumiko Jodai, Koichi Saruwatari, Kei Muramoto, et al.
Cell Death & Disease|January 9, 2026
Mycobacterium avium infection induced PD-L1 overexpression in macrophages: a potential involvement with immune escapeHiromu Yano, Yukio Fujiwara, Remi Mito, et al.
Internal Medicine (Tokyo, Japan)|November 15, 2021
Pembrolizumab-related Immune Thrombocytopenia in a Patient with Lung Adenocarcinoma Treated by Radiotherapy: Potential Immune-related Adverse Event Elicited by Radiation TherapyDaisuke Tamanoi, Koichi Saruwatari, Kosuke Imamura, et al.
Respiratory Investigation|September 24, 2024
Negative-predictive value of SUVmax for Ascertaining the efficacy of osimertinib in EGFR mutation-positive non-small cell lung cancerMoriyasu Anai, Hiroki Inoue, Koichi Saruwatari, et al.
Anticancer Research|February 4, 2019
Upfront Cranial Radiotherapy Followed by Erlotinib Positively Affects Clinical Outcomes of Epidermal Growth Factor Receptor-mutant Non-small Cell Lung Cancer With Brain MetastasesKoichi Saruwatari, Tokunori Ikeda, Sho Saeki, et al.
International Journal of Molecular Sciences|December 23, 2020
Heterogeneous Tumor-Immune Microenvironments between Primary and Metastatic Tumors in a Patient with <i>ALK</i> Rearrangement-Positive Large Cell Neuroendocrine CarcinomaTakahiro Tashiro, Kosuke Imamura, Yusuke Tomita, et al.
Journal of Thoracic Disease|March 20, 2024
Negative impact of ratio of the microvascular area to tumor area on the response to EGFR-TKI in non-small cell lung cancer with an <i>EGFR</i> mutationMoriyasu Anai, Koichi Saruwatari, Kosuke Imamura, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2022
Aging-associated and CD4 T-cell-dependent ectopic CXCL13 activation predisposes to anti-PD-1 therapy-induced adverse eventsHirotake Tsukamoto, Yoshihiro Komohara, Yusuke Tomita, et al.
Respiratory Investigation|June 1, 2026
Clinical significance of <sup>18</sup>F-FDG uptake in interstitial lung lesions in lung cancer patients with interstitial lung disease treated with immune checkpoint inhibitor therapyTsuguhiro Furukawa, Kimitaka Akaike, Koichi Saruwatari, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Cancer Research|July 22, 2021
TGFβ Signaling Activated by Cancer-Associated Fibroblasts Determines the Histological Signature of Lung AdenocarcinomaRyo Sato, Kosuke Imamura, Takashi Semba, et al.
Internal Medicine (Tokyo, Japan)|December 25, 2024
A Case of Rapid Emergence of Small-cell Carcinoma due to Malignant Transformation or de novo Formation in the Anterior Mediastinum Following Thymoma Resection: The Importance of a Re-biopsyYasumiko Jodai, Koichi Saruwatari, Kei Muramoto, et al.
Cell Death & Disease|January 9, 2026
Mycobacterium avium infection induced PD-L1 overexpression in macrophages: a potential involvement with immune escapeHiromu Yano, Yukio Fujiwara, Remi Mito, et al.
Internal Medicine (Tokyo, Japan)|November 15, 2021
Pembrolizumab-related Immune Thrombocytopenia in a Patient with Lung Adenocarcinoma Treated by Radiotherapy: Potential Immune-related Adverse Event Elicited by Radiation TherapyDaisuke Tamanoi, Koichi Saruwatari, Kosuke Imamura, et al.
Respiratory Investigation|September 24, 2024
Negative-predictive value of SUVmax for Ascertaining the efficacy of osimertinib in EGFR mutation-positive non-small cell lung cancerMoriyasu Anai, Hiroki Inoue, Koichi Saruwatari, et al.
Anticancer Research|February 4, 2019
Upfront Cranial Radiotherapy Followed by Erlotinib Positively Affects Clinical Outcomes of Epidermal Growth Factor Receptor-mutant Non-small Cell Lung Cancer With Brain MetastasesKoichi Saruwatari, Tokunori Ikeda, Sho Saeki, et al.
International Journal of Molecular Sciences|December 23, 2020
Heterogeneous Tumor-Immune Microenvironments between Primary and Metastatic Tumors in a Patient with <i>ALK</i> Rearrangement-Positive Large Cell Neuroendocrine CarcinomaTakahiro Tashiro, Kosuke Imamura, Yusuke Tomita, et al.
Journal of Thoracic Disease|March 20, 2024
Negative impact of ratio of the microvascular area to tumor area on the response to EGFR-TKI in non-small cell lung cancer with an <i>EGFR</i> mutationMoriyasu Anai, Koichi Saruwatari, Kosuke Imamura, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2022
Aging-associated and CD4 T-cell-dependent ectopic CXCL13 activation predisposes to anti-PD-1 therapy-induced adverse eventsHirotake Tsukamoto, Yoshihiro Komohara, Yusuke Tomita, et al.
Respiratory Investigation|June 1, 2026
Clinical significance of <sup>18</sup>F-FDG uptake in interstitial lung lesions in lung cancer patients with interstitial lung disease treated with immune checkpoint inhibitor therapyTsuguhiro Furukawa, Kimitaka Akaike, Koichi Saruwatari, et al.
Pageof 3